RenovoRx, Inc. (RNXT)
1.67
+0.19
(+12.84%)
USD |
NASDAQ |
Aug 28, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
RenovoRx Total Liabilities (Quarterly) : 2.493M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.493M |
| March 31, 2026 | 2.699M |
| December 31, 2025 | 2.722M |
| September 30, 2025 | 3.128M |
| June 30, 2025 | 3.002M |
| March 31, 2025 | 2.857M |
| December 31, 2024 | 3.719M |
| September 30, 2024 | 2.96M |
| June 30, 2024 | 2.732M |
| March 31, 2024 | 3.021M |
| December 31, 2023 | 4.466M |
| Date | Value |
|---|---|
| September 30, 2023 | 3.513M |
| June 30, 2023 | 5.126M |
| March 31, 2023 | 1.305M |
| December 31, 2022 | 1.102M |
| September 30, 2022 | 1.102M |
| June 30, 2022 | 1.123M |
| March 31, 2022 | 1.406M |
| December 31, 2021 | 0.938M |
| September 30, 2021 | 0.625M |
| June 30, 2021 | 19.22M |
| March 31, 2021 | 17.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 195.80M |
| Travere Therapeutics, Inc. | 774.84M |
| REGENXBIO, Inc. | 314.85M |
| Krystal Biotech, Inc. | 141.52M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.47M |
| Shareholders Equity (Quarterly) | 8.979M |
| Debt to Equity Ratio | 0.0434 |
| Current Ratio | 5.738 |
| Net Debt Paydown Yield | -0.05% |